At ProPharma Group, we understand the challenges you face in reaching pediatric patients and their families, in addition to the burdens they face in participating in a clinical trial. That’s why our experienced clinical development team can design a trial that helps you reach a more diverse patient population, as well as meet enrollment and retention throughout. We leverage our in-house decentralized clinical trials services to meet patients where they are and eliminate the difficulties associated with managing busy family schedules.
If you don’t need a full-service CRO to support your study, we can provide a small team of experts within a specific function. We can provide support to you where you need it most.
Pediatrics Expertise by Indication
We have supported clinical trials across a variety of indications affecting pediatric patients across the US, Canada, and Europe.
Decentralized Visits in Rare Disease Studies
The COVID-19 pandemic caused major disruption to many clinical trials and the participants receiving treatment. The risk of exposure for pediatric rare disease patients and their families was particularly challenging and stressful. Reduced travel options compounded by the risk for exposure during travel or at the Site, affected the entire family.
Get Expert Guidance for Your Pediatrics Clinical Trials
We understand what it takes to successfully implement a clinical trial involving pediatric patient populations and the unique challenges that come with it. If you don’t have the expertise to manage your pediatric study, ProPharma Group is here for you.
Contact us today to connect with a member of our team and tell us how we can help.